Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 21 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 9765302

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  2. US 9758556

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  3. US 9758555

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  4. US 9752118

    Method of directed differentiation producing corneal endothelial cells from neural crest stem cells by PDGFB and DKK2, compositions thereof, and uses thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  5. US 9730897

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  6. US 9730989

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  7. US 9732333

    Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

    Protalix Ltd. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  8. US 9731011

    Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  9. US 9732114

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  10. US 9725492

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  11. US 9725698

    Trophoblast-derived mesenchymal stem cells (T-MSCs) produced from human embryonic stem cells, methods and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  12. US 9713628

    Transplantation of neural cells

    The Regents of the University of California · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted
  13. US 9701713

    Compositions and methods for introduction of macromolecules into cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  14. US 9700639

    Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

    Aura Biosciences, Inc. · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  15. US 9700583

    Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

    REGENERATIVE SCIENCES, LLC · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  16. US 9682107

    Postnatal stem cells and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  17. US 9682151

    Peptides whose uptake in cells is controllable

    The Regents of the University of California · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  18. US 9676823

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Rhode Island Council on Postsecondary Education (statutory successor to Board of Governors for Higher Education, State of Rhode Island and Providence Plantations) · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  19. US 9662488

    Systems and methods for selectively migrating cells using electric fields

    The Regents of the University of California · Granted May 30, 2017 · Expires May 25, 2037

    granted
  20. US 9657267

    Ex host maturation of germline stem cells

    PrimeGen Biotech LLC · Granted May 23, 2017 · Expires May 18, 2037

    granted
  21. US 9657269

    Regulatory B cells (tBREGS) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted
  22. US 9649340

    Methods for producing enriched populations of human retinal pigment epithelium cells

    Astellas Institute for Regenerative Medicine · Granted May 16, 2017 · Expires May 11, 2037

    granted
  23. US 9644238

    Methods of isolating non-senescent cardiac stem cells and uses thereof

    AUTOLOGOUS REGENERATION, LLC · Granted May 9, 2017 · Expires May 4, 2037

    granted
  24. US 9644179

    Use of PDL1 expressing cells to convert T cells into regulatory T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2017 · Expires May 4, 2037

    granted